North American Gets Cancer Treatment OK
14th Nov 2006, 17:59 GMT
Cancer diagnostics and treatment products company North American Scientific said the FDA approved a high-dose radiation version of its breast cancer treatment.
North American Gets Cancer Treatment OK related news:
- North American gets FDA approval for breast cancer treatment — Latest news from Los Angeles Business from bizjournals
- Cancer treatment of black women delayed — United Press International - Consumer Health
- Shorter-course Radiation Treatment Safe For Breast Cancer — Health News from Medical News Today
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer — News-Medical News Feed
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System — FDA News News from StratCenter.com
- ORLive Presents: Robot-Assisted Radical Prostatectomy for the Treatment of Prostate Cancer Reduced Postoperative Pain, Offers Faster Recovery and May Produce Better Potency Rates — RedOrbit News - Health
- Risk after colon cancer higher for the very fat and very thin — EurekAlert! - Breaking News
- Recurrent breast cancer: Drug shows promise — The Cancer Blog
- slp3D: ORLive Presents: Robot-Assisted Radical Prostatectomy for the Treatment of Prostate Cancer Reduced Postoperative Pain, Offers Faster Recovery and May Produce Better Potency Rates — Market Wire - Medical and Healthcare
- New Treatment Finds Success, Long Survival In Treating Tiniest Lung Tumors, — Health News from Medical News Today
Latest news from FDA News News from StratCenter.com:
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System
- Newly FDA Approved SmartLipo Laser Liposuction Available at the Intimate Rejuvenation and Innovative Surgery Center, Phoenix, AZ.
- ACT-AD Coalition Calls FDA's New Focus on Neurological Diseases a Positive 1st Step
- Ivax Diagnostics Delays Filing 3Q Report
- New Corporate Members and Leaders for C-Path's Predictive Safety Testing Consortium Announced
- Diagnosoft Receives FDA Approval for Cardiac MRI Quantitative Regional Function Software Based on the HARP Technology
- PAREXEL Consulting Expands Risk Mgmt Expertise, Appoints Former FDA Consumer Safety Officer Raymond T Oji as Senior Consultant
- Trubion Pharmaceuticals to Present at the Lazard Life Sciences Conference
- Critical Therapeutics Announces Efficacy Data for Controlled-Release Formulation of Zileuton Presented at ACAAI 2006 Annual Meeting
- FermaVir's Founder and Board Member Professor Chris McGuigan receives the Royal Society of Chemistry's Award for Medicinal Chemistry